Pivmecillinam
| Clinical data | |
|---|---|
| Trade names | Selexid, Melysin, Coactabs, others | 
| Other names | amdinocillin pivoxil (USAN US) | 
| AHFS/Drugs.com | Monograph | 
| License data | |
| Routes of administration | By mouth | 
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | Low | 
| Protein binding | 5 to 10% (as mecillinam) | 
| Metabolism | Pivmecillinam is hydrolyzed to mecillinam | 
| Elimination half-life | 1 to 3 hours | 
| Excretion | Kidney and biliary, mostly as mecillinam | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.046.600 | 
| Chemical and physical data | |
| Formula | C21H33N3O5S | 
| Molar mass | 439.57 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Pivmecillinam (INN), or amdinocillin pivoxil (USAN), sold under the brand name Selexid and Pivya among others, is an orally active prodrug of mecillinam, an extended-spectrum penicillin antibiotic. Pivmecillinam is the pivaloyloxymethyl ester of mecillinam.